Overview

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Status:
Completed

Trial end date:
2001-08-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with autologous peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus peripheral stem cell transplantation in treating patients who have relapsed non-Hodgkin's lymphoma.

Phase:

Phase 2

Details

Lead Sponsor:

Fox Chase Cancer Center

Collaborator:

National Cancer Institute (NCI)

Treatments:

Cyclophosphamide
Cytarabine
Etoposide
Melphalan
Mitoxantrone
Paclitaxel